EYE – TREATMENT – AUSTRALIA

Azura heads for final studies for world-first dry eye treatment

roymorgansocial Leave a comment

Original article by Yolanda Redrup
The Australian Financial Review – Page: 21 : 8-Mar-21

Biotech start-up Azura Opthalmics is seeking to develop a treatment for a type of dry eye ailment known as meibomian gland dysfunction, which impacts over 30 million people in the US alone. Meibomian gland dysfunction can occur naturally as people age, but it can also be triggered or made worse by co-morbidities such as rheumatoid arthritis. Azura Opthalmics released promising phase two clinical trial results for its treatment in the week ending 5 March, while its backers include Brandon Capital, OrbiMed and Ganot Capital.

CORPORATES
AZURA OPTHALMICS, BRANDON CAPITAL PARTNERS PTY LTD, ORBIMED ADVISORS LLC, GANOT CAPITAL

Pulse sees value in $162m Vision Eye Institute bid

roymorgansocial Leave a comment

Original article by Yolanda Redrup
The Australian Financial Review – Page: 16 : 7-Jul-15

Australian-listed private hospital group Pulse Health is offering 1.6 of its shares for every share in Vision Eye Institute, valuing the bid at $A0.88 per share. The deal has the support of Viburnum Funds, which holds major stakes in both groups and would be the largest stakeholder in the combined entity.

CORPORATES
PULSE HEALTH LIMITED – ASX PHG, VISION EYE INSTITUTE LIMITED – ASX VEI, VIBURNUM FUNDS PTY LTD, PRIMARY HEALTH CARE LIMITED – ASX PRY

Bionic eye closer to trials on humans

roymorgansocial Leave a comment

Original article by Bridie Smith
The Age – Page: 8 : 3-Dec-14

Monash University is matching dollar-for-dollar the donations by the charitable foundations of chancellor Alan Finkel and entrepreneur Marc Besen to the Monash Vision Group. The funding of $A3m in total will enable the bionic eye researchers to proceed to human trials in 2015. The expenditure on the project has averaged $A2.5m per annum, but Monash Vision director Arthur Lowery notes that there will be no further grants by the Australian Research Council. Monash Vision is a joint effort of Monash University, Alfred Health, MiniFAB and Grey Innovation

CORPORATES
MONASH VISION PTY LTD, MONASH UNIVERSITY, ALFRED HEALTHCARE GROUP, MINIFAB (AUST) PTY LTD, GREY INNOVATION PTY LTD, BIONIC VISION AUSTRALIA, AUSTRALIAN RESEARCH COUNCIL, AUSTRALIA. NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL, BESEN FAMILY FOUNDATION